| |
All (n = 92a)
|
Women (n = 44a)
|
Men (n = 48a)
|
|---|
|
Variable
|
Baseline
|
1 year
|
2 years
|
Baseline
|
1 year
|
2 years
|
Baseline
|
1 year
|
2 years
|
|---|
|
BMD studies performed
|
92
|
66
|
48
|
44
|
31
|
22
|
48
|
35
|
26
|
|
Anti-fracture therapy in prior year
|
-
|
4 (6.1)
|
10 (20.8)
|
-
|
3 (9.7)
|
6 (27.3)
|
-
|
1 (2.9)
|
4 (15.4)
|
|
Glucocorticoid in prior year
|
-
|
3 (4.5)
|
5 (10.4)
|
-
|
2 (6.5)
|
5 (22.7)
|
-
|
1 (2.9)
|
0 (0)
|
|
BMD measurement
|
|
Femur T-score
|
- 0.8 (±1.5)
|
-1.0 (±1.4)
|
- 1.1 (±1.3)
|
- 1.2 (±1.4)
|
- 1.3 (±1.2)
|
- 1.4 (±0.9)
|
- 0.5 (±1.4)
|
- 0.7 (±1.5)
|
- 1.0 (±1.6)
|
|
Femur absolute (g/cm3)
|
0.956 (±0.197)
|
0.940 (±0.193)
|
0.923 (±0.178)
|
0.876 (±0.176)
|
0.872 (±0.161)
|
0.871 (±0.126)
|
1.028 (±0.187)
|
0.999 (±0.202)
|
0.964 (±0.203)
|
|
AP spine T-score
|
- 0.2 (±1.9)
|
- 0.2 (±1.9)
|
- 0.1 (±1.9)
|
- 0.7 (±1.8)
|
- 0.6 (±1.6)
|
- 0.5 (±1.2)
|
0.3 (±1.8)
|
0.2 (±2.0)
|
0.3 (±2.2)
|
|
AP spine absolute (g/cm3)
|
1.207 (±0.242)
|
1.205 (±0.241)
|
1.211 (±0.231)
|
1.135 (±0.250)
|
1.142 (±0.223)
|
1.151 (±0.173)
|
1.273 (±0.217)
|
1.260 (±0.246)
|
1.262 (±0.264)
|
- Data are shown as mean (±standard deviation) or number (%)
-
Abbreviations: BMD bone mineral density, AP anterioposterior
-
aAt baseline femur BMD not measured in three participants (one woman, two men). At 1 year femur BMD not measured in two participants (one woman, one man), at 2 years femur BMD not measured in one participant (one woman)
